Immunoassay Markets (Infectious Disease, Tumor Markers, Thyroid, Allergy, Drugs of Abuse, Therapeutic Drug Monitoring, Others)

Sep 6, 2017
470 Pages - Pub ID: KLI15468656
Share this report
 
Online Download $4,500
Departmental Site License (one location, 10 users) $6,750
Global Site License $9,000

Immunoassay Markets (Infectious Disease, Tumor Markers, Thyroid, Allergy, Drugs of Abuse, Therapeutic Drug Monitoring, Others)

Visit our 'Immunoassays' curated page for all-in-one industry coverage.

The immunoassay market is a large, well-established market with billions in sales. This market consists of three major segments: immunoassays performed in centralized laboratories for clinical indications such as screening, diagnosis, and/or monitoring patients, point-of-care or rapid immunoassays also performed for clinical indications, and immunoassays performed to screen the blood supply to prevent transfusion-transmitted infections.

Immunoassays are tests that are based on the binding of antibodies to antigens to identify the presence of a substance (an analyte). Immunoassays have been used in clinical laboratory medicine since the 1960s, and are indispensable tools in clinical diagnostics. A wide range of types of immunoassays is now used to measure proteins (including antibodies), hormones, drugs, and other analytes. Fully automated immunoassay systems are now found in clinical laboratories. Even though the field of immunoassays is now mature, companies have continued to develop new immunoassays and immunoassay instrument platforms to improve the sensitivity of the assays. New developments are designed to make multiplexing possible, to miniaturize the platforms for point-of¬care, and to identify and develop assays for novel biomarkers, thus further expanding the potential of immunoassays for the future.

Immunoassay Market Data, Including:

  • Global Immunoassay Market, 2017-2021
  • Historical Market 2014-2016
  • ELISA Markets
  • Radioimmunoassay Markets
  • Lab-based Immuonassay Markets
  • POC Immumonassays
  • Infectious Disease Immunoassays - (Hepatitis, HIV, STD, TORCH, Respiratory, HAIs, Other Infectious Disease)
  • Tumor Marker Immunoassays
  • Thyroid
  • Metabolic and Other Hormone Immunoassays
  • Therapeutic Drug Monitoring Immunoassays
  • Drugs of Abuse Immunoassays
  • Transplant Medicine, IBD, Alzheimer's and Other Areas of Disease Innovation
  • Instrument Platforms
  • International and Emerging Markets
  • Company Profiles
Prospects for growth in the immunoassay market are good in certain geographical regions of the world (developing countries). Several factors are driving the growth of diagnostic testing, including testing with lateral flow devices, in these markets. One major factor is economics. There is a growing middle class population that is increasingly insured in many countries in South East Asia and Latin America, and these patients are better able to pay for services. In addition, increased availability of health insurance in emerging companies such as China and India is helping to fuel this growth. These and other factors will make these regions promising segments of the immunoassay market. The report provides more specific data regarding immunoassay growth.

Immunoassay Market Segments

The central lab-based immunoassays market is by far the largest segment of the total immunoassay market with 70.6% of this market in 2016. Centralized laboratories include reference laboratories (such as Laboratory Corporation of America or LabCorp, Quest Diagnostics, and others), hospital laboratories, laboratories operated by health maintenance organizations (HMOs), and other centralized laboratories. These laboratories range from very high volume labs down to smaller labs, but they typically use the fully automated immunoassay and chemistry/immunoassay analyzers discussed in the report for their high volume immunoassay tests. They may also have other platforms for tests that are not as high volume, and therefore are not on the fully automated platforms.

The market for point-of-care (POC) testing consists of two segments, self-testing (also referred to as the over-the-counter or OTC segment), and professional POC testing. However, there are many locations where POC testing can occur within these segments, especially the professional POC market. Professional POC testing is performed in a number of different settings including in hospitals, physicians office laboratories (POLs) and clinics, retail clinics, and many other locations.

Immunoassays also play a role in blood testing (or blood screening) market, which represents only 3.5% of the total immunoassay market. In developed countries, all units of blood and blood products are already screened for several infectious agents. Growth of the blood testing market in these countries is primarily driven by changes in the numbers of units donated and being screened. An exception and potentially significant step increase in the size of this market could occur if it is mandated that a new (additional) immunoassay be used to screen blood for an additional disease. In some developing countries, not all units of blood and blood products are screened for every recommended infectious agent. Additional growth could occur in these markets as more of the blood supply is screened. However, Kalorama expects that the overall, worldwide market for immunoassays used to screen blood will continue to grow slowly.

Market data in this report are based on factory sales to the end user, and not on retail pricing or reimbursement payments. The dollar value of a market segment is proportional to the number of tests performed, because the cost of the instrumentation is generally buried in the per test price.
1: EXECUTIVE SUMMARY
OVERVIEW

SCOPE AND METHODOLOGY

MARKET OVERVIEW

Table 1-1: Global Immunoassay Market 2014-2021 (in millions % at manufacturer level)

COMPETITIVE SUMMARY

FUTURE PROSPECTS IN THE IMMUNOASSAY MARKET
2: INTRODUCTION

HISTORY AND FUTURE OF IMMUNOASSAYS

POINT OF VIEW


3: TECHNOLOGY, TRENDS AND INNOVATIONS

OVERVIEW – IMMUNOASSAYS

ELISA


Radioimmunoassays

OVERVIEW – INSTRUMENT PLATFORMS

Automation

Platform Innovations – Miniaturization, Microfluidics and Multiplexed Assays

Table 3-1: Selected Innovations in Immunoassay Platforms
SPECIMEN TYPES
Blood

Urine

Saliva

Table 3-2: Selected Companies with Saliva or Oral-Fluid Collection Devices

4: MARKET SEGMENT BY TYPE OF LABORATORY

CENTRALIZED LABORATORIES
Companies Marketing to Centralized Laboratories

Table 4-1: Selected Companies Marketing Central Lab-Based Immunoassays Worldwide

RAPID AND POINT-OF-CARE TESTING

POC Testing in Hospitals

Physician’s Office Laboratories and Clinics

Retail Clinics


Other Professional POC Testing

Self-Testing

Companies Marketing Immunoassay for POC Testing

Table 4-2: Selected Companies Marketing Immunoassay sand/or Lateral Flow Tests for POC Worldwide

BLOOD TESTING

Table 4-3: Selected Companies Marketing Immunoassay Platforms for Blood Screening Worldwide

5: IMMUNOASSAY DIAGNOSTIC MARKET ACTIVITY BY DISEASE CATEGORY

Table 5-1: Immunoassay Market Disease Categories

INFECTIOUS DISEASE

Hepatitis

Retroviral

Sexually Transmitted Diseases

TORCH

Other Infectious Diseases –Immunoassays in Central Laboratories

Rapid and POC Testing

Blood Testing

Table 5-2: Selected Infectious Disease Immunoassays

Table 5-3: Selected Companies Marketing Immunoassasys for Infectious Disease

TUMOR MARKERS

Table 5-4: Selected Tumor Marker Immunoassays

Table 5-5: Selected Companies Marketing Immunoassasys for Tumor Markers

CARDIAC MARKERS

Table 5-6: Selected Cardiac Marker Immunoassays

Table 5-7: Selected Companies Marketing Immunoassasys for Cardiac Markers

FERTILITY/PREGNANCY/REPRODUCTIVE HORMONES

Table 5-8: Selected Fertility and Reproductive Hormone Immunoassays

Table 5-9: Selected Companies Marketing Immunoassasys for Fertility/Pregnancy/Reproductive Hormone Diagnostics

THYROID

Table 5-10: Selected Thyroid Hormone Immunoassays

Table 5-11: Selected Companies Marketing Immunoassasys for Thyroid Hormone Diagnostics

METABOLIC DISORDERS AND OTHER HORMONES

Table 5-12: Selected Metabolic and Other Hormone Immunoassays

Table 5-13: Selected Companies Marketing Metabolic and Other Immunoassasys

THERAPEUTIC DRUG MONITORING

Table 5-14: Selected Therapeutic Drug Monitoring Immunoassays

Table 5-15: Selected Companies Marketing Immunoassasys for Therapeutic Drug Monitoring

DRUGS OF ABUSE

Table 5-16: Selected Drugs of Abuse Immunoassays

Table 5-17: Selected Companies Marketing Immunoassays for Drugs of Abuse

ALLERGY

Table 5-18: Selected Allergy Immunoassays (Does not include all companies marketing allergy tests)

Table 5-19: Selected Companies Marketing Immunoassays for Allergy Diagnostics

AUTOIMMUNE DISEASE

Table 5-20: Selected Autoantibodies Detected by Autoimmune Immunoassays

Table 5-21: Selected Companies Marketing Immunoassays for Autoimmune Disease

OTHER DISEASE CATEGORIES IN IMMUNOASSAY DISEASE MARKET

Table 5-22: Selected Other Immunoassays

6: MARKET OPPORTUNITIES AND ISSUES FOR IMMUNOASSAYS

IMMUNOASSAY MARKET – MARKET DRIVERS AND CHANGES

NEW AND EMERGING AREAS OF IMMUNOASSAY INNOVATION

Gastrointestinal Disorders

Table 6-1: Selected Inflammatory Bowel Disease Test Innovations

Transplant Management

Table 6-2: Selected Immunoassays Innovations for Transplant Medicine

Preeclampsia

Table 6-3: Selected Immunoassays Innovations for Preeclampsia

Alzheimer’s Disease

Table 6-4: Selected Immunoassay Innovations for Alzheimer’s Disease

Table 6-5: Selected New and Emerging Biomarkers Detected by Immunoassays

Table 6-6: Selected Immunoassay Innovations

EMERGING INTERNATIONAL MARKETS

Table 6-7: Selected Companies Outside of North America, Europe, or Japan Marketing Immunoassays

OUTLOOK FOR IMMUNOASSAYS

7: IMMUNOASSAY MARKET ANALYSIS

MARKET OVERVIEW AND MARKET SEGMENTS

Table 7-1: Global Immunoassay Market 2014-2021 (in millions % at manufacturer level)

Figure 7-1: Global Immunoassay Market Segments by Type of Laboratory Test 2016

Central Lab-based Immunoassay Market

Table 7-2: Global Lab-based Immunoassay Market 2014-2021 (in millions % at manufacturer level)

POC Immunoassay Market

Table 7-3: Global POC Immunoassay Market 2014-2021 (in millions % at manufacturer level)

Table 7-4: Global POC Immunoassay Testing Market Analysis by Product Category 2016 (in millions $)

Figure 7-2: Global POC Immunoassay Testing Market Analysis by Product Category Percent 2016

Blood Screening Immunoassay Market

Table 7-5: Global Blood Screening Immunoassay Market 2014-2021 (in millions % at manufacturer level)136

Immunoassay Market by Product Type

Figure 7-3: Global Immunoassay Market Share % by type of product 2016

Immunoassay Market by Technology Type

Figure 7-4: Global Immunoassay Market Share by Technology (Chemiluminesce, Fluorescence, RIA, ELISA) 2016

COMPETITIVE ANALYSIS

Table 7-6: Global Immunoassay Market Analysis by Competitor Revenues and Market Share % 2016

Figure 7-5: Global Immunoassay Market Analysis by Competitor Market Share % 2016

LAB-BASED IMMUNOASSAYS BY DISEASE CATEGORY

Table 7-7: Global Lab-based Market Analysis by Disease Category, 2016 (in millions$)

Figure 7-6: Global Lab-based Market Analysis by Disease Category, 2016

Table 7-8: Global Lab-based Infectious Disease Immunoassay Sales 2016 [Hepatitis, HIV, STD, TORCH, Respiratory, HAIs, Other 
Infectious Disease (in millions$)

Figure 7-7: Global Lab-based Infectious Disease Immunoassay Market Share % 2016

Table 7-9: Global Lab-based Tumor Marker Immunoassay Sales 2016 (in millions$)

Figure 7-8: Global Lab-based Tumor Marker Immunoassay Market Share % 2016

POINT OF CARE/RAPID TEST IMMUNOASSAYS BY DISEASE CATEGORY

Table 7-10: Global POC Immunoassay Market Analysis by Disease Category, 2016 (in millions$)

Figure 7-9: Global POC Immunoassay Market Analysis by Disease Category Market Share %, 2016

IMMUNOASSAY MARKET BY GEOGRAPHIC REGIONS

Table 7-11: Immunoassay Market by Geographic Region 2016

Figure 7-10: Immunoassay Market % by Geographic Region 2016

Table 7-12: Immunoassay Market by Geographic Region 2021

Figure 7-11: Immunoassay Market % by Geographic Region 2021

Europe

Table 7-13: Immunoassay Market by European Geographic Region 2016

Figure 7-12: Immunoassay Market Share % by European Geographic Region 2016

Rest of World

Table 7-14: Immunoassay Market by Rest of World Geographic Region 2016

Figure 7-13: Immunoassay Market Share % by Rest of World Geographic Region 2016

PROGNOSIS FOR GROWTH OF THE IMMUNOASSAY MARKET

Table 7-15: Selected New Immunoassay Technologies 2016
8: COM
PANY PROFILES

\1 STEP DETECT ASSOCIATES, LLC
T
able 8-1: 1-Step Detect Associates Corporate Summary

Company Overview

Products

ABBOTT LABORATORIES

Table 8-2: Abbott Corporate Summary

Company Overview

Product

Company Financials

Table 8-3: Abbott Laboratories Revenue (2013-2016) ($ millions)

ABINGDON HEALTH, LTD.

Table 8-4: Abingdon Health Corporate Summary

Company Overview

Products

ACCESS BIO, INC.

Table 8-5: Access Bio Summary

Company Overview

Products

ACCUBIOTECH CO, LTD.

Table 8-6: AccuBioTech Summary

Company Overview

Products

ACCUTECH, LLC

Table 8-7: Accutech Corporate Summary

Company Overview

Products

ACON LABORATORIES, INC

Table 8-8: ACON Laboratories Corporate Summary

Company Overview

Products

AESKU. DIAGNOSTICS

Table 8-9: AESKU.DIAGNOSTICS Corporate Summary

Company Overview

Products

AKERS BIOSCIENCES, INC.

Table 8-10: Akers Biosciences Corporate Summary

Company Overview

Products

Company Financials

Table 8-11: Akers Biosciences (2013-2016) ($ millions)

ALERE INC

Table 8-12: Alere Corporate Summary

Company Overview

Product

Company Financials

Table 8-13: Alere Revenue (2013-2016) ($ millions)

ALFA SCIENTIFIC DESIGNS, INC

Table 8-14: Alfa Scientific Designs Summary

Company Overview

Products

AMERICAN LABORATORY PRODUCTS COMPANY (ALPCO)

Table 8-15: American Laboratory Products Corporate Summary

Company Overview

Products

AMERICAN BIO MEDICA CORPORATION

Table 8-16: American Bio Medica Summary

Company Overview

Products

Company Financials

Table 8-17: American Bio Medica Revenue (2013-2016) ($ thousands)

AMNISURE INTERNATIONAL

Table 8-18: Amnisure International Corporate Summary

Company Overview

Products

ARK DIAGNOSTICS, INC.

Table 8-19: ARK Diagnostics Corporate Summary

Company Overview

Products

ARKRAY, INC

Table 8-20: ARKRAY Corporate Summary

Company Overview

Products

ARLINGTON SCIENTIFIC, INC.

Table 8-21: Arlington Scientific Corporate Summary

Company Overview

Products

ARTRON LABORATORIES INC.

Table 8-22: Artron Laboratories Corporate Summary

Company Overview

Products

ASSOCIATES OF CAPE COD, INC. (ACC)

Table 8-23: Associates of Cape Cod Corporate Summary

Company Overview

Products

ASTRA BIOTECH GMBH

Table 8-24: Astra Biotech Corporate Summary

Company Overview

Products

ATLAS GENETICS LTD.

Table 8-25: Atlas Genetics Corporate Summary

Company Overview

Products

ATLAS LINK BIOTECH CO., LTD

Table 8-26: Atlas Link Biotech Summary

Company Overview

Products

AUDIT DIAGNOSTICS

Table 8-27: Audit Diagnostics Corporate Summary

Company Overview

Products

AUGURIX DIAGNOSTIC

Table 8-28: Augurix Diagnostic Summary

Company Overview

Products

AUTOBIO DIAGNOSTICS CO., LTD

Table 8-29: Autobio Diagnostics Summary

Company Overview

Products

AVIOQ, INC.

Table 8-30: Avioq Corporate Summary

Company Overview

Products

AWARENESS TECHNOLOGY

Table 8-31: Awareness Technology Corporate Summary

Company Overview

Products

AXA DIAGNOSTICS S.R.L.

Table 8-32: AXA Diagnostics Corporate Summary

Company Overview

Products

AXIS SHIELD DIAGNOSTICS LTD.

Table 8-33: Axis Shield Corporate Summary

Company Overview

Products

BECKMAN COULTER, INC

Table 8-34: Beckman Coulter Corporate Summary

Company Overview

Products

Company Financials

Table 8-35: Beckman Coulter (2013-2016) ($ millions)

BECTON DICKINSON (BD)

Table 8-36: BD Corporate Summary

Company Overview

Products

Company Financials

Table 8-37: BD (2013-2016) ($ millions)

BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO., LTD.

Table 8-38: Beijing Wantai Biological Pharmacy Enterprise Corporate Summary

Company Overview

Products

BG MEDICINE, INC.

Table 8-39: BG Medicine Corporate Summary

Company Overview

Products

BHAT BIO-TECH INDIA PRIVATE LTD. (BBI)

Table 8-40: Bhat Bio-Tech India Private Corporate Summary

Company Overview

Products

BINDING SITE GROUP LTD.

Table 8-41: Binding Site Group Corporate Summary

Company Overview

Products

BIOCARE DIAGNOSTICS LTD.

Table 8-42: Biocare Diagnostics Corporate Summary

Company Overview

Productsi

BIOCHECK, INC

Table 8-43: Biocheck Corporate Summary

Company Overview

Products

BIOHIT OYJ (BIOHIT HEALTHCARE)

Table 8-44: Biohit Oyj Corporate Summary

Company Overview

Products

Company Financials

Table 8-45: Biohit Oyj (2013-2016) ($ millions)

BIOKIT S.A.

Table 8-46: Biokit Corporate Summary

Company Overview

Products

BIOLYTICAL LABORATORIES

Table 8-47: bioLytical Laboratories Summary

Company Overview

Products

BIOMERICA

Table 8-48: Biomerica Summary

Company Overview

Products

Company Financials

Table 8-49: Biomerica (2013-2016) ($ millions)

BIOMERIEUX SA

Table 8-50: bioMerieux SA Corporate Summary

Company Overview

Products

Company Financials

Table 8-51: bioMerieux Revenues (2013-2016) ($ millions)

BIOPORTO DIAGNOSTICS

Table 8-52: BioPorto Diagnostics Corporate Summary

Company Overview

Products

Company Financials

Table 8-53: BioPorto Diagnostics (2013-2016) ($ millions)

BIO-RAD LABORATORIES INC

Table 8-54: Bio-Rad Labs Corporate Summary

Company Overview

Products

Company Financials

Table 8-55: Bio-Rad Labs (2013-2016) ($ millions)

BIOSCAN SCREENING SYSTEMS, INC.

Table 8-56: Bioscan Screening Systems Corporate Summary

Company Overview
Products

BIOSCIENCE (TIANJIN) DIAGNOSTIC TECHNOLOGY CO., LTD.

Table 8-57: Bioscience (Tianjin) Diagnostic Technology Corporate Summary

Company Overview

Products

BIOTECH ATLANTIC, INC.

Table 8-58: Biotech Atlantic Corporate Summary

Company Overview

Products

BIO-TECHNE

Table 8-59: Bio-Techne Corporate Summary

Company Overview

Products

Company Financials

Table 8-60: Bio-Techne (2013-2016) ($ millions)

BIOTRON DIAGNOSTICS, INC.

Table 8-61: Biotron Diagnostics Corporate Summary

Company Overview

Products

BNTX INC.

Table 8-62: BTNX Corporate Summary

Company Overview
Products

BOSON BIOTECH CO. LTD

Table 8-63: Boson Biotechl Summary

Company Overview

Products

BUHLMANN LABORATORIES AG

Table 8-64: BUHLMANN Laboratories Summary

Company Overview

Products

CALYPTE BIOMEDICAL CORPORATION

Table 8-65: Calypte Biomedical Summary

Company Overview

Products

CARE PRODUCTS, INC.

Table 8-66: CARE Products Corporate Summary

Company Overview
Products

CERTEST BIOTEC

Table 8-67: CerTest Biotec Summary

Company Overview

Products
CHEMBIO DIAGNOSTIC SYSTEMS, INC.

Table 8-68: Chembio Diagnostic Corporate Summary

Company Overview

Products
Company Financials

Table 8-69: Chembio Diagnostics Revenues (2013-2016) ($ millions)

CISBIO BIOASSAYS

Table 8-70: Cisbio Bioassays Corporate Summary

Company Overview
Products

CLARITY DIAGNOSTICS, LLC

Table 8-71: Clarity Diagnostics Corporate Summary

Company Overview

Products

CONFIRM BIOSCIENCES

Table 8-72: Confirm Biosciences Corporate Summary

Company Overview

Products

CTK BIOTECH, INC.
Table 8-73: CTK Biotech Corporate Summary
Company Overview
Products
DIAGENICS LTD.

Table 8-74: Diagenics Corporate Summary

Company Overview

Products


DIALAB GMBH

Table 8-75: DIALAB Summary

Company Overview

Products

DIAMETRA
Table 8-76: Diametra Corporate Summary
Company Overview
Products

DIASORIN S.P.A.

Table 8-77: DiaSorin Corporate Summary

Company Overview

Products

Company Financials

Table 8-78: DiaSorin (2013-2016) ($ millions)

DIASOURCE IMMUNOASSAYS SA

Table 8-79: Diasource ImmunoAssays Corporate Summary

Company Overview

Products

DIASYS DIAGNOSTIC SYSTEMS GMBH

Table 8-80: DiaSys Diagnostic Systems Corporate Summary

Company Overview

Products

DIAXOHIT

Table 8-81: Diaxohit Corporate Summary

Company Overview

Products

DIAZYME LABORATORIES, INC.

Table 8-82: Diazyme Laboratories Corporate Summary

Company Overview

Products

DR. FOOKE-ACHTERRATH LABORATORIEN GMBH

Table 8-83: Dr. Fooke-Achterrath Laboratorien Corporate Summary

Company Overview

Products

DRG INTERNATIONAL, INC.

Table 8-84: DRG International Corporate Summary

Company Overview

Products

EIKEN CHEMICAL CO LTD.

Table 8-85: Eiken Chemical Corporate Summary

Company Overview

Products

Company Financials

Table 8-86: Eiken Chemical Revenue (2013-2016) ($ millions)

EKF DIAGNOSTICS HOLDINGS PLC

Table 8-87: EKF Diagnostics Corporate Summary

Company Overview

Products

Company Financials

Table 8-88: EKF Diagnostics Revenue (2013-2016) ($ millions)

ELITECHGROUP, INC.

Table 8-89: ELITechGroup Corporate Summary

Company Overview

Products

ERBA DIAGNOSTICS, INC.

Table 8-90: ERBA Diagnostics Corporate Summary

Company Overview

Products

Company Financials

Table 8-91: ERBA Diagnostics (2013-2016) ($ millions)

EUROIMMUN AG

Table 8-92: Euroimmun AG Corporate Summary

Company Overview

Products

Company Financials

Table 8-93: EUROIMMUN Revenue (2013-2016) ($ millions)

EUROSPITAL S.P.A.

Table 8-94: Eurospital Summary

Company Overview

Products

EY LABORATORIES

Table 8-95: EY Laboratories Summary

Company Overview

Products

FIRST CHECK DIAGNOSTICS LLC

Table 8-96: First Check Diagnostics Corporate Summary

Company Overview

Products

FUJIREBIO US, INC.

Table 8-97: Fujirebio Corporate Summary

Company Overview

Products

GENBIO

Table 8-98: GenBio Corporate Summary

Company Overview

Products

GETEIN BIOMEDICAL, INC.

Table 8-99: GeTein Corporate Summary

Company Overview

Products

GLYSBY SNC

Table 8-100: GlysBy Corporate Summary

Company Overview

Products

GOLD STANDARD DIAGNOSTICS

Table 8-101: Gold Standard Diagnostics Corporate Summary

Company Overview

Products

GRIFOLS INTERNATIONAL S.A.

Table 8-102: Grifols International S.A. Corporate Summary

Company Overview

Products
Company Financials

Table 8-103: Grifols (2013-2016) ($ millions)

HEMA DIAGNOSTIC SYSTEMS, LLC

Table 8-104: Hema Diagnostics Systems Corporate Summary

Company Overview

Products

HEMOSURE, INC.

Table 8-105: Hemosure Corporate Summary

Company Overview

Products

HOB BIOTECH

Table 8-106: HOB Biotech Corporate Summary

Company Overview

Products

HYCOR BIOMEDICAL, INC.

Table 8-107: HYCOR Biomedical Corporate Summary

Company Overview


Products

IMMUNODIAGNOSTIC SYSTEMS LTD. (IDS)

Table 8-108: Immunodiagnostic Systems Corporate Summary

Company Overview

Products

Company Financials

Table 8-109: IDS (2013-2016) ($ millions)

IMMUNO-MYCOLOGICS, INC.

Table 8-110: Immuno-Mycologics Corporate Summary

Company Overview

Products

IMMUNOSCIENCES LAB, INC.

Table 8-111: Immunosciences Lab Corporate Summary

Company Overview

Products

IMMUNOSTICS, INC

Table 8-112: Immunostics Corporate Summary

Company Overview

Products

INBIOS INTERNATIONAL, INC.

Table 8-113: InBios Corporate Summary

Company Overview

INOVA DIAGNOSTICS, INC

Table 8-114: Inova Diagnostics Corporate Summary


Company Overview

Products

JANT PHARMACAL CORPORATION

Table 8-115: Jant Pharmacal Summary

Company Overview

Products


KRONUS

Table 8-116: Kronus Corporate Summary

Company Overview

Products


LABSYSTEMS DIAGNOSTICS OY

Table 8-117: Labsystems Diagnostics Corporate Summary

Company Overview

Products

LIFESIGN, LLC

Table 8-118: LifeSign Summary

Company Overview


LUMINEX CORPORATION

Table 8-119: Luminex Corporate Summary


Company Overview


Products

Company Financials

Table 8-120: Luminex (2013-2016) ($ millions)

MEDIX BIOCHEMICA


Table 8-121: Medix Biochemica Summary

Company Overview

Products

MEDMIRA, INC


Table 8-122: MedMira Corporate Summary

Company Overview

Products

Company Financials


Table 8-123: MedMira. (2013-2016) ($ millions)


MERCODIA AB

Table 8-124: Mercodia AB Summary

Company Overview
Products


MERIDIAN BIOSCIENCE, INC

Table 8-125: Meridian BioScience Corporate Summary

Company Overview


Products

Company Financials

Table 8-126: Meridian Bioscience Revenue (2013-2016) ($ millions)


MONOBIND, INC

Table 8-127: Monobind Corporate Summary

Company Overview

Products

NANO-DITECH CORPORATION


Table 8-128: Nano-Ditech Corporate Summary


Company Overview

Products

NOVA BIOMEDICAL, CORP.

Table 8-129: Nova Biomedical Corporate Summary


Company Overview

Products

NOVATEC IMMUNODIAGNOSTICA GMBH

Table 8-130: Novatec Immunodiagnostica Corporate Summary



Company Overview


Products

OASIS DIAGNOSTICS CORPORATION

Table 8-131: Oasis Diagnostics Corporate Summary

Company Overview


Products

ONCIMMUNE HOLDINGS PLC.
Table 8-132: Oncimmune Corporate Summary


Company Overview

Products

Company Financials


Table 8-133: Oncimmune Revenue (2013-2016) ($ millions)

ONE LAMBDA


Table 8-134: One Lambda Corporate Summary

Company Overview

Products


OPERON

Table 8-135: Operon Corporate Summary

Company Overview

Products

OPKO HEALTH, INC

Table 8-136: OPKO Health Corporate Summary


Company Overview

Products

Company Financials

Table 8-137: OPKO Health Revenue (2013-2016) ($ millions)


ORASURE TECHNOLOGIES, INC.

Table 8-138: OraSure Technologies Corporate Summary


Company Overview

Products

Company Financials


Table 8-139: OraSure Revenue (2013-2016) ($ millions)
ORGENTEC DIAGNOSTIKA GMBH

Table 8-140: Orgentec Diagnostika Corporate Summary

Company Overview

Products

ORION DIAGNOSTICA OY

Table 8-141: Orion Diagnostica Corporate Summary




Company Overview

Products

ORTHO CLINICAL DIAGNOSTICS

Table 8-142: Ortho Clinical Diagnostics Corporate Summary

Company Overview

Products

Company Financials

Table 8-143: Ortho Clinical Diagnostics Revenue (2013-2016) ($ millions)

POLYMEDCO, INC

Table 8-144: Polymedco Corporate Summary

Company Overview

Products

QUALIGEN, INC.

Table 8-145: Qualigen Corporate Summary

Company Overview

Products

QUANTERIX CORPORATION

Table 8-146: Quanterix Corporate Summary

Company Overview

Products

QUIDEL CORPORATION

Table 8-147: Quidel Corporate Summary

Company Overview

Products

Company Financials

Table 8-148: Quindel Revenue (2013-2016) ($ millions)

PREVENTIS GMBH

Table 8-149: Preventis Corporate Summary

Company Overview

Products

PRINCETON BIOMEDITECH CORPORATION

Table 8-150: Princeton Biomeditech Corporate Summary

Company Overview

Products

PROTAGEN AG

Table 8-151: Protagen Corporate Summary

Company Overview

Products

RADIOMETER MEDICAL A/S

Table 8-152: Radiometer Medical Corporate Summary

Company Overview

Products

Company Financials

\Table 8-153: Radiometer Revenue (2013-2016) ($ millions)
RANDOX LABORATORIES LTD.

Table 8-154: Randox Laboratories Corporate Summary

Company Overview

Products

RELIA DIAGNOSTICS, INC
Table 8-155: ReLia Diagnostics Corporate Summary

Company Overview

Products

RENESA UG


Table 8-156: RENESA UG Corporate Summary

Company Overview

Products

RESPONSE BIOMEDICAL CORP


Table 8-157: Response Biomedical Corporate Summary

Company Overview

Products

Company Financials

Table 8-158: Response Biomedical Revenue (2013-2016) ($ millions)

RESZON DIAGNOSTICS INTERNATIONAL SDN. BHD.

Table 8-159: Reszon Diagnostics Corporate Summary


Company Overview

Products

ROCHE DIAGNOSTIC CORPORATION

Table 8-160: Roche Corporate Summary

Company Overview

Products

Company Financials

Table 8-161: Roche Revenue (2013-2016) ($ millions)

SAVYON DIAGNOSTICS LTD.

Table 8-162: Savyon Diagnostics Summary

Company Overview

Products

SEKISUI DIAGNOSTICS

Table 8-163: Sekisui Diagnostics Summary

Company Overview

Products

SIEMENS HEALTHINEERS

Table 8-164: Siemens Healthineers Corporate Summary

Company Overview

Products

Company Financials

Table 8-165: Siemens Healthineers Revenue (2013-2016) ($ millions)

SINGULEX, INC

Table 8-166: Singulex Corporate Summary

Company Overview

Products

STANDARD DIAGNOSTICS, INC.

Table 8-167: Standard Diagnostics Corporate Summary

Company Overview

Products

SYNTRON BIORESEARCH, INC.

Table 8-168: Syntron Bioresearch Corporate Summary

Company Overview

Products

TECHLAB, INC.

Table 8-169: TECHLAB Corporate Summary

Company Overview

Products

TECO DIAGNOSTICS

Table 8-170: Teco Diagnostics Corporate Summary

Company Overview

Products

THERADIAG

Table 8-171: Theradiag Corporate Summary

Company Overview

Products

Company Financials

Table 8-172: Theradiag (2013-2016) ($ millions)

THERMO FISHER SCIENTIFIC, INC

Table 8-173: Thermo Fisher Scientific Corporate Summary

Company Overview

Products

Company Financials

Table 8-174: Thermo Fisher Scientific (2013-2016) ($ millions)

TOSOH BIOSCIENCE, INC.

Table 8-175: Tosoh Bioscience Corporate Summary

Company Overview

Products

Company Financials

Table 8-176: Tosoh Corporation (2013-2016) ($ millions)

TRINITY BIOTECH PLC

Table 8-177: Trinity Biotech Corporate Summary

Company Overview

Products

Company Financials

Table 8-178: Trinity Biotech Revenue (2013-2016) ($ millions)

TRUE DIAGNOSTICS

Table 8-179: True Diagnostics Corporate Summary

Company Overview

Products

VIRCELL

Table 8-180: Vircell Corporate Summary

Company Overview

Products

VOLITIONRX LIMITED

Table 8-181: VolitionRx Corporate Summary

Company Overview

Products

WAKO DIAGNOSTICS

Wako Life Sciences

Table 8-182: Wako Diagnostics Corporate Summary

Company Overview

Products

WAMA DIAGNOSTICA

Table 8-183: WAMA Diagnostica Corporate Summary

Company Overview

Products

WERFEN GROUP

Table 8-184: Werfen Group Corporate Summary

Company Overview

ZEUS SCIENTIFIC, INC.

Table 8-185: Zeus Scientific Corporate Summary

Company Overview

Products



In this report, {{keyword[keywordTextProperty]}} appears {{keyword[keywordCountProperty]}} times. {{searchResults.STATRESULT.SUMMARY.KW[keywordTextProperty]}} appears {{searchResults.STATRESULT.SUMMARY.KW[keywordCountProperty]}} times.

We were unable to search inside this report.

Search for an exact word or phrase by placing the word or phrase in quotation marks ("market trend"). Search for different versions or tenses of a word by placing an asterisk at the end of the word (pharma*).

Please note that your term must be at least three characters long and numbers will be blocked by the # sign.